Key facts
- This page summarizes Steven H. Stein's Form 4 filing for INCYTE CORP (INCY).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 21 Jan 2026, 16:06.
Steven H. Stein - 16 Jan 2026 Form 4 Insider Report for INCYTE CORP (INCY)
- Reporting relationship
- EVP & Chief Medical Officer
- Issuer ticker
- INCY
- Reported as of
- 16 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Jan 2026, 16:06:29 UTC
- Prior SEC filing
- 07 Jan 2026
- Next SEC filing
- 17 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth Feeney, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steven H. Stein filed Form 4 for INCYTE CORP (INCY) on 21 Jan 2026.
Change
- Previous filing in this sequence was filed on 07 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001673776
Primary reporting owner
Stein Steven H
- Relationship
- EVP & Chief Medical Officer
- Address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON
- Signature
- /s/ Elizabeth Feeney, Attorney-In-Fact
- Signature date
- 21 Jan 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INCY
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +19,932
- Change %
- Price
- $0.000000
- Shares after
- 19,932
- Date
- 16 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,932
- Exercise price
- $106.21
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Beginning January 16, 2026, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2026 and the remainder vesting monthly over three years.